In addition, BBR can improve the hepatic fat content, apolipoprotein B (Apo B), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) in patients with NAFLD (Yan et al., 2015). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.